CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-02 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −48,626 | 0 | ||
| 2026-01-30 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale | −5,885 | $82.95 | $488K | 100,293 |
| 2026-01-29 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award | +11,421 | 106,178 | ||
| 2026-01-16 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale | −8,977 | $75.15 | $675K | 94,757 |
| 2026-01-15 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise | +21,055 | 103,734 | ||
| 2026-01-15 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award · Performance Restricted Stock Units | +25,800 | 89,282 | ||
| 2026-01-15 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise · Restricted Stock Unit | −21,055 | 17,434 | ||
| 2026-01-15 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award · Restricted Stock Unit | +9,675 | 27,109 | ||
| 2026-01-02 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +19,350 | 19,350 | ||
| 2025-09-05 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −6,000 | $59.60 | $358K | 82,679 |
| 2025-09-03 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise 10b5-1 | +46,800 | $53.77 | $2.5M | 135,479 |
| 2025-09-03 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −33,909 | $60.62 | $2.1M | 101,570 |
| 2025-09-03 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise 10b5-1 | −12,891 | $61.50 | $793K | 88,679 |
| 2025-09-03 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −46,800 | 0 | ||
| 2025-09-02 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −5,000 | $49.14 | $246K | 88,679 |
| 2025-08-29 | BENNETT C FRANK EVP, Chief Scientific Officer | Other acquisition | +213 | $27.71 | $6K | 93,679 |
| 2025-08-18 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise 10b5-1 | +10,000 | $32.60 | $326K | 103,466 |
| 2025-08-18 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −10,000 | $43.98 | $440K | 93,466 |
| 2025-08-18 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −10,000 | 18,869 | ||
| 2025-02-28 | BENNETT C FRANK EVP, Chief Scientific Officer | Other acquisition | +320 | $28.21 | $9K | 93,466 |
Page 2 of 3 · 42 trades